Forte Biosciences Inc.
17.16
2.54 (17.37%)
At close: Jan 15, 2025, 1:43 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue n/a n/a n/a n/a n/a 18.04M 41.00K 49.00K 51.00K
Cost of Revenue 9.00K n/a 36.00K 54.00K 11.00K n/a n/a n/a n/a
Gross Profit -9.00K n/a -36.00K -54.00K -11.00K 18.04M 41.00K 49.00K 51.00K
Operating Income -32.49M -13.90M -21.49M 17.83M -4.06M -45.85M -37.63M -31.69M -22.95M
Interest Income 1.12M n/a n/a n/a n/a n/a 595.00K n/a n/a
Pretax Income -31.48M -13.88M -21.71M -46.49M -4.07M -47.26M -38.93M -33.48M -23.06M
Net Income -31.48M -13.86M -21.71M -78.54M -4.07M -48.95M -38.93M -33.48M -23.06M
Selling & General & Admin 10.62M 8.30M 7.63M 4.22M 1.38M 12.81M 8.27M 4.27M 3.60M
Research & Development 21.86M 5.59M 13.85M 10.00M 2.68M 50.45M 29.11M 27.22M 19.17M
Other Expenses -1 17.00K -222.00K -205.00K -6.85K n/a n/a -50.00K n/a
Operating Expenses 32.48M 13.90M 21.49M 14.22M 4.06M 63.26M 37.38M 31.48M 22.77M
Interest Expense n/a n/a n/a n/a n/a 173.38K 1.93M -1.84M -102.00K
Selling & Marketing Expenses -9.00K n/a n/a n/a n/a 12.54M -292.00K -255.00K -232.00K
Cost & Expenses 32.49M 13.90M 21.49M 14.22M 4.06M 63.89M 37.67M 31.74M 23.00M
Income Tax n/a -17.00K -200.56K 32.06M -2.52K 1.70M -2.60M -3.67M -204.00K
Shares Outstanding (Basic) 1.26M 695.34K 558.71K 294.36K 84.33K 53.49K 38.95K 52.74K 48.63K
Shares Outstanding (Diluted) 1.26M 695.34K 558.71K 294.36K 84.33K 53.49K 38.95K 52.74K 48.63K
EPS (Basic) -24.92 -19.96 -38.85 -157.93 -48.25 -915.18 -997.5 -634.8 -474.15
EPS (Diluted) -24.92 -19.96 -38.85 -157.93 -48.25 -915.18 -997.5 -634.8 -474.15
EBITDA -32.48M -13.90M -21.45M -46.43M -4.05M -43.69M -36.70M -31.17M -22.48M
Depreciation & Amortization 9.00K 36.00K 36.00K 54.00K 11.00K 625.00K 292.00K 255.00K 232.00K

Create Price Alert on FBRX

Your price alert will notify you when the stock price is above 17.16.

Add to Watchlist